Q. Cai

发表

Discovery of 8-(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-4H-[1,2,3]triazolo[4,5-c]quinolin-4-one (CQ211) as a Highly Potent and Selective RIOK2 Inhibitor.

Zhong Liu, Zhang Zhang, Yifan Ouyang, 2022, Journal of medicinal chemistry.

Hybrid compounds as new Bcr/Abl inhibitors.

Xiang Li, X. Li, Xiaoyun Lu, 2011, Bioorganic & medicinal chemistry letters.

Design of Small‐Molecule Peptidic and Nonpeptidic Smac Mimetics

Shaomeng Wang, Chao-yie Yang, Z. Nikolovska-Coleska, 2009 .

Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants.

Honglin Li, Shaomeng Wang, Shiliang Li, 2013, Angewandte Chemie.

A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.

Tao Zhang, Dajun Yang, Su Qiu, 2011, Journal of medicinal chemistry.

Design and synthesis of novel cytotoxic podophyllotoxin derivatives

Zhiyan Xiao, Wenying Xi, Hua Sun, 2010 .

Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.

Liu Liu, Shaomeng Wang, Jianfeng Lu, 2012, Journal of medicinal chemistry.

Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases.

Dajun Yang, Su Qiu, Han Yi, 2008, Journal of medicinal chemistry.

Design of small-molecule peptidic and nonpeptidic Smac mimetics.

Su Qiu, Jianfeng Lu, Shaomeng Wang, 2008, Accounts of chemical research.

Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors.

Xiangbao Meng, Zhang Zhang, Lijie Peng, 2023, European journal of medicinal chemistry.

Identification and Development of 1,4-Diaryl-1,2,3-triazolo-Based Ureas as Novel FLT3 Inhibitors.

F. Zhou, Zheng-chao Tu, Sihua Zhu, 2020, ACS medicinal chemistry letters.

Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.

Liu Liu, Shaomeng Wang, Xueliang Fang, 2012, Journal of medicinal chemistry.

Recent developments in the third generation inhibitors of Bcr-Abl for overriding T315I mutation.

Xiaoyun Lu, Q. Cai, Ke Ding, 2011, Current Medicinal Chemistry.